Ticker
VRDNCompany Name
VIRIDIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -309.6M | $ -3.79 | 1 | 81.59M |
3/31/2025 | $ -280.35M | $ -3.45 | 1 | 81.34M |
12/31/2024 | $ -232.83M | $ -3.43 | 1 | 67.89M |
9/30/2024 | $ -197.43M | $ -2.97 | 1 | 66.42M |
6/30/2024 | $ -168.82M | $ -2.64 | 1 | 63.85M |
3/31/2024 | $ -168.2M | $ -2.75 | 1 | 61.1M |
12/31/2023 | $ -185.07M | $ -4.14 | 1 | 44.76M |
9/30/2023 | $ -181.29M | $ -4.15 | 1 | 43.65M |
6/30/2023 | $ -162.67M | $ -3.76 | 1 | 43.25M |
3/31/2023 | $ -135.5M | $ -3.21 | 1 | 42.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for VIRIDIAN THERAPEUTICS INC is calculated as follows: FCF [ $ -28.2M ] / (Shares WA [ 3.72M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -7.58 ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.85 |
average | $ 0.8 |
median | $ 0.29 |
std | $ 2.82 |